Fig. 1From: Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)Schematic flowchart of the trial. PDAC, pancreatic ductal adenocarcinoma; S1-PTX, intravenous and intraperitoneal paclitaxel with S-1; GnP, gemcitabine plus nanoparticle albumin-bound (nab)-paclitaxelBack to article page